Barriat, S., van Wijck, F., Staecker, H. and Lefebvre, P.P. (2012) Intratympanic Steroid Therapy Using the Silverstein MicrowickTM for Refractory Sudden Sensorineural Hearing Loss Increases Speech Intelligibility. Audiology and Neurotology, 17, 105-111.
http://dx.doi.org/10.1159/000329367

has been cited by the following article:

• TITLE: Role of Intratympanic Steroids in the Management of Meniere’s Disease—A Review of 151 Cases

  AUTHORS: D. S. Deenadayal, D. Vidyasagar, Vyshanavi Bommakanti, Karuna Goel, Nabeelah Naeem

  KEYWORDS: Meniere’s, Intratympanic Steroids, Methyl Prednisolone

  JOURNAL NAME: International Journal of Otolaryngology and Head & Neck Surgery, Vol.5 No.2, March 24, 2016

  ABSTRACT: Objective: To assess the outcomes of hearing and vertigo in patients with Meniere’s disease who were treated with intratympanic methylprednisolone. Study Design: Retrospective study. Setting: Tertiary referral hospital. Methods: In our study with 151 patients [191 ears] were diagnosed as Menieres as per 1995 AAO-HNS guidelines. As an office based procedure these patients were treated with intratympanic methyl prednisolone. Results: There was a 98.6% improvement in the vertigo control rate, a 73.82% improvement in hearing and 29.31% had a definitive improvement in tinnitus. Conclusion: We conclude from our study that intratympanic steroid injection significantly controls vertigo, tinnitus and improves hearing in Meniere’s disease with minimal complications. Hence, it can be tried as a first line treatment for patients with Meniere’s disease.